As anti-viral it may prevent the release of infectious viral nucleic acid into the host cell. For treatment of parkinsonism, it may increase the release of dopamine from dopaminergic nerve terminals in the substancia nigra of Parkinson patients. As anticonvulsant, inhibition of carbonic anhydrase in the CNS increases carbon dioxide tension resulting to decrease neuronal conduction.
As anti-viral it may prevent the release of infectious viral nucleic acid into the host cell. For treatment of parkinsonism, it may increase the release of dopamine from dopaminergic nerve terminals in the substancia nigra of Parkinson patients. As anticonvulsant, inhibition of carbonic anhydrase in the CNS increases carbon dioxide tension resulting to decrease neuronal conduction.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
As anti-viral it may prevent the release of infectious viral nucleic acid into the host cell. For treatment of parkinsonism, it may increase the release of dopamine from dopaminergic nerve terminals in the substancia nigra of Parkinson patients. As anticonvulsant, inhibition of carbonic anhydrase in the CNS increases carbon dioxide tension resulting to decrease neuronal conduction.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
As anti-viral it may Absorption: symptomatic hypersensitivity, Depression, Obtain baseline
drug prevent the release well treatment of lactation CHF, Orthostatic assessment of patients of infectious viral Distribution: several forms of hypotensive exposures to influenza nucleic acid into wide Parkinson disease episodes, A viruses the host cell. This metabolism: or syndromes and psychosis, reaction appears to none drug induced urinary retenstion Assess allergies before be specific for excretion: extrapyramidal initiation of treatment influenza A. For kidneys (90% reactions treatment of unchanged) Monitor for possible parkinsonism, it half-life: drug induced adverse may increase the 24hours reaction release of dopamine from assess patient’s dopaminergic hydration if adverse GI nerve terminals in reaction occurs the substancia nigra of Parkinson patients Acetazolamide Cardiovascul Inhibits carbonic Absorption: GI Adjunctive Hypersensitivity to Drowsiness, Assess neurologic ar Drug anhydrase activity. Tract – 65% if treatment of 1. sulfonamides, paresthesia, status when using drug As anticonvulsant, fasting, 75% edema caused by severe renal or anxiety, for seizure inhibition of with food; IV- CHF or drug- hepatic diseases. depression, carbonic complete induced edema Electrolyte headache, assess for eye pain, anhydrase in the Distribution: and 2.) imbalances, dizziness, change in vision when CNS increases Cross placenta; centrencephalic hyperchloremic confusion, using drug for carbon dioxide widely epilepsies acidosis, Addison stimulatiom, intraocular pressure tension resulting to distributed disease, long term fatigue, seizures, decrease neuronal Metabolism: use in narrow-angle sedation, and Assess fluid volume conduction None glaucoma nervousness, status Excretion: myopia, tinnitus, Kidney, huperglycemia, Monitor manifestations unchanged hypokalemia, of electrolyte (80% within 24 nausea, vomiting, imbalances hrs); breast anorexia, milk constipation, Assess for symptoms of Half-life: 2.5- uremia, acute mountain 5.5 hrs sickness